GlassScriptPhysician profile
Kanoelehua Perry
NPI 1205199312
$2,152.54
in general payments reported to CMS, 2019-2025
16 companies · $438 in 2025
The $438 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $18.44 · 2021: $16.66 · 2022: $53.04 · 2023: $502 · 2024: $999 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,938.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $546.17 | 2021-2025 | |
| Astellas Pharma US INC | $537.43 | 2023-2025 | Veozah |
| Ortho Development Corporation | $284.61 | 2024 | |
| Exeltis, USA INC. | $122.02 | 2024-2025 | Slynd |
| Amgen INC. | $111.09 | 2023-2025 | Evenity, Prolia, Prolia |
| Abbvie INC. | $110.71 | 2019-2025 | |
| Pfizer INC. | $96.26 | 2023-2025 | |
| Evofem Biosciences, INC. | $69.34 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $65.18 | 2023-2025 | Myfembree, Gemtesa |
| Roche Diagnostics Corporation | $56.01 | 2019-2020 | |
| Astellas Pharma Global Development | $35.00 | 2024 | Veozah |
| Myovant Sciences INC. | $27.32 | 2022 | |
| Radius Health, INC. | $26.85 | 2019 | |
| Ethicon US, LLC | $24.31 | 2019 | |
| Merck Sharp & Dohme LLC | $20.77 | 2023 | Vaxneuvance, Pneumovax 23, Gardasil 9 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $19.47 | 2023 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kanoelehua Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.